LogicBio Therapeutics is a clinical-stage genetic medicine company that is at the forefront of pioneering gene delivery and gene editing platforms to address rare diseases. With a strong focus on delivering the hope of genetic medicine to patients with rare diseases, LogicBio Therapeutics harnesses the body's natural DNA repair process to provide precise, stable, and durable therapies. Committed to improving the lives of young patients, LogicBio Therapeutics is dedicated to providing one-time treatments with durable results.

Their groundbreaking work in developing a safer, site-specific genome-editing technology called GeneRide™ sets them apart as industry leaders. Driven by their passion for helping patients, LogicBio Therapeutics has made rapid progress towards their goal. With an extensive library of publications, as well as patient stories that highlight the positive impact of their therapies, they continue to push boundaries in the field of genetic medicine.

Stay up to date with the latest news and events from LogicBio Therapeutics as they strive to make a difference in the lives of patients with rare genetic diseases